Health · 34 views
Scientists cautiously suggest GLP-1s are safe to use around pregnancy
A new study from the University of St Andrews suggests weight-loss drugs like Ozempic taken around pregnancy do not raise the risk of major birth defects.
AI Summary
Scientists from the University of St Andrews conducted a study on GLP-1 receptor agonists, including Ozempic, and pregnancy. The study, published in the American Journal of Obstetrics and Gynaecology, found no increased risk of major birth defects among over 49,000 pregnancies exposed to these medications. The review spanned 20 years.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow